The pharmaceutical company Jingyao Pharmaceutical shared at 9:30 yesterday has become the new leader: the "Dinghai Shenzhen" in a day of widespread gains, with the "Dragon Head Not Speaking Top."

Today is April 1st, Fool’s Day, but the market isn’t pulling any pranks on anyone. [TaoGuba]
The $JinYao Pharmaceutical(sh600488)$ that I shared at yesterday’s open has already become the overall market’s top leader.

Because the U.S. and Iran situation is getting hot ahead of time, the broad market opened higher and rose more.

But as a short-term trader—especially one who’s watching the opening auction—this morning I was actually a bit “bored,” because on the ultra-short side, there were no new targets to place trades.

Why? Not because the brightest star in the market is already in our positions. Instead, it’s because the broad market is broadly up and opening strong—on such a day, it’s actually harder for ultra-short consecutive-limit-up relay to work.

1. The opening auction decides everything: no new opportunities—yesterday’s target is the best opportunity

At 9:15 a.m., as usual, I opened my trading software and scanned the opening auction. To be honest, the expected new faces didn’t show up. Every sector had something popping up, but the auction strength and the quality of the limit-up orders were nowhere near the level of yesterday’s $JinYao Pharmaceutical(sh600488)$.

After 9:20 a.m., during the no-cancellation period, within just a few seconds of the open, $JinYao Pharmaceutical(sh600488)$ directly got sealed into a one-word limit-up. The order queue kept adding orders—going from over 100 million at the open. At the same time, I noticed a detail: Kailaiying, Zhaoyan New Drug, and Kanglong Chemical, which had risen with it yesterday, all opened high today in the auction as well; the sector effect is continuing.

On a broad-up day, what you fear most is the visual overload of everything jumping and chasing highs everywhere. But the leader’s one-word acceleration actually helps us do subtraction: since the strongest one is still in its main upswing, there’s no need to settle for second best.
Sure enough, not long after the open, I also commented in the post: “There are no new targets today—hold the position with $JinYao Pharmaceutical$.” This isn’t a complaint; it’s confirmation. The market completes its differentiation during a broad-up move, and after that differentiation, the funds only recognize the leader. On broad-up days, the rally is often a concentrated release of sentiment, not the true emergence of structural opportunities. $JinYao Pharmaceutical$ today directly accelerated on shrinking volume, indicating that the market has already formed a consensus. When a stock like this can turn into an independent trend in a weak market, on broad-up days it’s even more likely to become an “anchor” that funds rally around.

2. $JinYao Pharmaceutical$: from a “consecutive-limit stock” to a leap into the overall market’s top leader

In yesterday’s article, I broke down in detail why I chose $JinYao Pharmaceutical$: its auction attitude, sector resonance, and the chip structure. And today, it tells us with its price action that it is no longer just a simple consecutive-limit stock—it has become the emotional anchor for the entire market.
A few signals are worth paying attention to:

1. The younger brothers help out, and the ranks are complete
   During today’s trading, the entire medicine sector line was fully activated. Not only innovative drugs—traditional Chinese medicine and APIs all followed higher. When a sector can form a complete tiered structure (leader consecutive-limit, mid-tier trend, and low-position first boards), it means this isn’t a one-day wonder; it shows that funds are building a main line. As the one who led first, $JinYao Pharmaceutical$ benefits from the liquidity premium of the whole sector.

2. Accelerating on shrinking volume, with chips highly locked in
   Today it shrank volume on a one-word board; the turnover rate is extremely low. Combined with yesterday’s data from the龙虎榜 (Dragon & Tiger Board) showing institutional selling and how speculators accepted, we can infer: the “not-so-steady chips” that needed to be sold have already been cleared; what remains is capital that is bullish and keeps adding. This chip structure is the most ideal state for a leader during its main upswing.

3. From “individual stock opportunities” to “market consensus”
   In the morning, I said in the post: “It’s very strong—one after another of the younger brothers are helping out.” By the lunch break, I said: “The stronger it goes, the more likely you won’t be able to buy tomorrow.” That’s not just感慨; it’s based on an objective judgment of what’s happening on the board. When a stock becomes a target that the whole market can’t get around, its rise no longer needs reasons—it becomes the reason itself.

4. On a broad-up day: speculators’ “subtraction” and “addition”

Many people think that in a broad-up rally, there should be green everywhere and you should grab limit-ups all over. But based on my many years of experience, broad-up days are actually among the easiest days to lose money.
Why? Because when sentiment is running high, it makes people relax their stock-picking standards and chase some “looks pretty good” follow-on stocks. The result is often: the leader keeps hitting the limit-up, the followers spike then fall back, and the next day you’re forced to gap down and stop-loss.
My actions today are actually very simple: subtract—no new positions, just holding what I have; add—continue to hold firmly on the leader, letting profits run.
I also shared this mindset in the post: “There’s no homework today. If there is homework, it will be sent out. Usually, when there’s no homework, holding to yesterday’s homework is the safest approach.”
These words are for both my followers and for myself. In short-term trading, the hardest part isn’t catching opportunities—it’s holding your hand when there isn’t a confirmed one.

4. Tomorrow’s plan: the leader won’t say it’s the top, but you should have numbers in mind

Now that $JinYao Pharmaceutical$ has come to this point, it has already become the widely recognized overall market leader. For tomorrow’s movement, I won’t make a prediction—I’ll only prepare responses:

If it continues its one-word acceleration: then keep the position and enjoy the premium of the main upswing. Once this kind of stock becomes market consensus, the sky is the limit.

If it opens on volume intraday: observe turnover and acceptance. If the retest for a close is strong, it’s still an opportunity to add or do T (turnover trades); if acceptance is weak, then consider realizing gains in batches.

Also, I’ll keep watching the sector’s continuity. Today the entire medicine line already feels like it’s “taking over the screen.” If this heat can be maintained, the leader’s safety buffer will be thicker.

In the end, as always: the end of the leader isn’t about prediction—it’s about response.

At the close today, we’re still on the vehicle. Tomorrow, if there are new opportunities, I’ll still share them in the comments section of this article.

If you finished reading and want to research opening-auction opportunities together, add my Special Following, like and save the article, and in the comments section reply to register and clock in.